Sirohia & Sons Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 1,425,000 (48%) | — | ₹171 Cr |
| Retail | — | 1,425,000 (48%) | — | ₹171 Cr |
| Market Maker | — | 150,000 (5%) | — | ₹2 Cr |
| Σ Total | — | 3,000,000 (100%) | — | ₹3,600 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 10,000 | ₹120,000 |
| Retail (Max) | 13 | 130,000 | ₹1,560,000 |
| S-HNI (Min) | 14 | 140,000 | ₹1,680,000 |
| B-HNI (Min) | 67 | 670,000 | ₹8,040,000 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Long Term Working Capital – 2.70
- 2 General corporate purpose – 0.40
- 3 Issue Expenses – 0.50
Company Overview
Incorporated in 1990, Sirohia & Sons is engaged in the business of dealing in fertilizers and pesticides catering primarily to Tea Industry located in the North East region of the Country, particularly the state of Assam and West Bengal. It receives orders of the specific fertilizers and pesticides required by the Tea Estates through its direct marketing and procure them from the manufacturers which are mostly multinational companies like BASF India Limited, Bayer Cropscience India Limited, Biostadt India Limited, DIC India Limited etc,.
Some of the products which the company is deal in includes DELTAMETHREINE, CYPERMETHRIN, BACILLUS, THIACLOPRID and METHOMYL.